Short- and long-term benefits of drug-eluting stents compared to bare metal stents even in treatment for large coronary arteries

[1]  Takeshi Kimura,et al.  Transradial versus transfemoral approach in patients undergoing primary percutaneous coronary intervention for ST-elevation acute myocardial infarction: insight from the CREDO-Kyoto AMI registry , 2017, Heart and Vessels.

[2]  H. Tada,et al.  Initial and late efficacy of everolimus-eluting stents for small and non-small coronary lesions from evaluating delayed late loss study , 2017, Heart and Vessels.

[3]  K. Hayashi,et al.  Early endothelialization associated with a biolimus A9 bioresorbable polymer stent in a porcine coronary model , 2017, Heart and Vessels.

[4]  David O. Williams,et al.  Comparison of drug‐eluting and bare metal stents in large coronary arteries , 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[5]  K. Hayashi,et al.  Impact of lesion morphology and associated procedures for left main coronary stenting on angiographic outcome after intervention: sub-analysis of Heart Research Group of Kanazawa, HERZ, Study , 2014, Cardiovascular Intervention and Therapeutics.

[6]  K. Node,et al.  The late-phase inflammatory response after drug-eluting stent implantation , 2014, Heart and Vessels.

[7]  F. Eberli,et al.  Improved two-year outcomes after drug-eluting versus bare-metal stent implantation in women and men with large coronary arteries: importance of vessel size. , 2013, International journal of cardiology.

[8]  Chao-Yung Wang,et al.  Long-term outcomes of drug-eluting stents versus bare-metal stents in large coronary arteries. , 2013, International journal of cardiology.

[9]  Shinichiro Tanaka,et al.  Long-term changes in neointimal hyperplasia following implantation of bare metal stents assessed by integrated backscatter intravascular ultrasound , 2013, Heart and Vessels.

[10]  Takeshi Kimura,et al.  Current antiplatelet therapy for Japanese patients with ST elevation acute myocardial infarction: J-AMI registry , 2013, Cardiovascular Intervention and Therapeutics.

[11]  K. Hayashi,et al.  Impact of out-stent plaque volume on in-stent intimal hyperplasia: results from serial volumetric analysis with high-gain intravascular ultrasound. , 2012, International journal of cardiology.

[12]  W. Wijns,et al.  Long-term clinical outcome in patients with small vessel disease treated with drug-eluting versus bare-metal stenting. , 2011, American heart journal.

[13]  M. Yamagishi,et al.  Impact of Severe Coronary Disease Associated or Not Associated with Diabetes Mellitus on Outcome of Interventional Treatment Using Stents: Results from HERZ (Heart Research Group of Kanazawa) Analyses , 2011, The Journal of international medical research.

[14]  F. Eberli,et al.  Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer the LEADERS trial substudy. , 2009, JACC. Cardiovascular interventions.

[15]  S. Shin,et al.  Bare-metal stents versus drug-eluting stents in large (≥3.5mm) single coronary artery: angiographic and clinical outcomes at 6 months. , 2009, Journal of cardiology.

[16]  Y. Hayashi,et al.  Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation , 2009, Circulation.

[17]  C. Reid,et al.  Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry. , 2008, International journal of cardiology.

[18]  B. Xu,et al.  Short- and long-term outcomes of single bare metal stent versus drug eluting stent in nondiabetic patients with a simple de novo lesion in the middle and large vessel , 2008, Journal of Translational Medicine.

[19]  John Bresnahan,et al.  Outcomes of Stent Thrombosis and Restenosis During Extended Follow-Up of Patients Treated With Bare-Metal Coronary Stents , 2007, Circulation.

[20]  P. Serruys,et al.  Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.

[21]  Marco Valgimigli,et al.  Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. , 2007, The New England journal of medicine.

[22]  K. Kent,et al.  Comparison of effectiveness of bare metal stents versus drug-eluting stents in large (> or =3.5 mm) coronary arteries. , 2007, The American journal of cardiology.

[23]  Neville Kukreja,et al.  Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study , 2007, The Lancet.

[24]  A. Kastrati,et al.  Vessel size and outcome after coronary drug-eluting stent placement: results from a large cohort of patients treated with sirolimus- or paclitaxel-eluting stents. , 2006, Journal of the American College of Cardiology.

[25]  K. Ono,et al.  Histopathological findings of new in‐stent lesions developed beyond five years , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[26]  E. Bramucci,et al.  Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial. , 2004, JAMA.

[27]  Patrick W Serruys,et al.  Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy , 2004, The Lancet.

[28]  J. Popma,et al.  The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). , 2004, Journal of the American College of Cardiology.

[29]  G. Stone,et al.  A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. , 2004, The New England journal of medicine.

[30]  Jeffrey W Moses,et al.  Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.

[31]  P. Serruys,et al.  A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. , 2002, The New England journal of medicine.

[32]  R. Gibbons,et al.  ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary , 2001 .

[33]  G. Stone,et al.  Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. , 1999, Circulation.